The U.S. Food and Drug Administration (FDA) has cleared two Kinetic Concepts, Inc. (KCI) next-generation V.A.C.® Therapy Systems: The InfoV.A.C.® Therapy System and the ActiV.A.C.® Therapy System. KCI’s V.A.C.® Therapy Systems are the only negative pressure wound therapy (NPWT) systems specifically cleared by the FDA for all care settings, including home use. These next generation technologies give physicians, care providers, and patients new features and benefits to ensure optimal delivery of safe and effective NPWT.
V.A.C.® Therapy is the controlled application of sub-atmospheric pressure to a wound using a therapy unit to intermittently or continuously convey negative pressure to a specialized wound dressing to help promote wound healing. The wound dressing is a resilient, open-cell foam surface dressing that assists tissue granulation and is sealed with an adhesive drape that contains the subatmospheric pressure at the wound site. Special technology enhances patient safety by regulating pressure at the wound site. Additionally, the V.A.C.® Therapy System helps direct drainage to a specially designed canister that reduces the risk of exposure to exudate fluids and infectious materials.
V.A.C.® Therapy helps enable caregivers to reach positive outcomes for a variety of chronic and acute wound types, such as pressure ulcers, diabetic wounds, abdominal wounds, partial-thickness burns, trauma wounds, flaps and grafts.
KCI is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces.
Illustration: Kinetic Concepts, Inc.
Street Insider (06/11/07)
Genetic Engineering & Biotechnology News (06/11/07)
Business Wire (06/11/07)
DBusiness News (06/12/07)